Non-Invasive Characterization of Focal Liver Lesions in Liver Cirrhosis

Launched by UNIVERSITY HOSPITAL, BONN · Nov 15, 2018

Keywords

ClinConnect Summary

This clinical trial is investigating how well non-invasive methods can identify and understand focal liver lesions in patients who have liver cirrhosis, a serious liver condition. The study is focusing on the accuracy of these non-invasive tests, which means they do not require surgery or other invasive procedures, to see how effectively they can help doctors diagnose and predict health outcomes for patients with these liver issues.

To join the study, participants must be adults aged 18 and older who have both focal liver lesions and liver cirrhosis. Unfortunately, those who cannot provide consent or are younger than 18 will not be eligible. If you participate, you can expect to undergo non-invasive tests that aim to provide important information about your liver condition, helping guide future treatment options. The trial is currently looking for volunteers, and your involvement could contribute valuable knowledge to improve care for others with similar health concerns.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • all patients with focal liver lesions and liver cirrhosis
• Exclusion Criteria:
• • no consent
• • under 18 years